Chonnam National University Hospital

Gwangju, Dong-gu 61469

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer Disease

Studies at this site

• Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD) — Running, not enrolling
• Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease — Stopped early
• Open-label Extension for Phase 3 Clinical Trials of Simufilam — Stopped early